Human Longevity Stock

www.humanlongevity.comHealthcare / BioTech & PharmaFounded: 2013Funding to Date: $69.48MM

Human Longevity is a genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data.

Register To Buy and Sell Shares

For more details on financing and valuation for Human Longevity, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Human Longevity’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Human Longevity.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Felix Frueh
Chief Scientific Officer
Yaron Turpaz
Chief Information Officer
Williams Biggs
Head, Genomic Sequencing
J. Venter
Co-founder and CEO

Board Members

David Brenner
University of California, San Diego
James Brewer
University of California, San Diego
Delos Cosgrove
Cleveland Clinic
Eric Anderson
Intentional Software

Human Longevity’s stock FAQs


Can you buy Human Longevity’s stock?

Human Longevity is not publicly traded on NYSE or NASDAQ in the U.S. To buy Human Longevity’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Human Longevity’s stock?

Yes, you can sell stock of a private company like Human Longevity. Forge can help you sell your Human Longevity stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Human Longevity’s stock price?

Human Longevity is a privately held company and therefore does not have a public stock price. However, you may access Human Longevity’s private market stock price with Forge Data.

What is Human Longevity’s stock ticker symbol?

Human Longevity does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Human Longevity plans to go public in $1B blank-check deal

The genome sequencing company plans to go public through a merger with Freedom Acquisition I Corp that values the combined company at about $1B.

Xconomy: NeoGenomics Nabs Human Longevity’s Oncology Division for $37M

The genetic testing company NeoGenomics has acquired Human Longevity’s oncology division, which provides next-generation sequencing services. The division

A Deeper Look At Human Longevity Genes

Dr. Nir Barzilai, a Milken Institute Center for the Future on Aging Longevity Innovator, discusses his latest research and what's ahead.
Updated on: Jul 12, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.